Literature DB >> 18556451

Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.

J A G van Roon, K Jacobs, S Verstappen, J Bijlsma, F Lafeber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18556451     DOI： 10.1136/ard.2007.081059

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  Cell-cell interactions in rheumatoid arthritis synovium.

Authors:  David A Fox; Alison Gizinski; Rachel Morgan; Steven K Lundy
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

2.  Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Authors:  Mahmood M T M Ally; Bridget Hodkinson; Pieter W A Meyer; Eustasius Musenge; Gregory R Tintinger; Mohammed Tikly; Ronald Anderson
Journal:  BMC Musculoskelet Disord       Date:  2015-05-29       Impact factor: 2.362

3.  Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis.

Authors:  Krista Kuuliala; Antti Kuuliala; Riitta Koivuniemi; Hannu Kautiainen; Heikki Repo; Marjatta Leirisalo-Repo
Journal:  Arthritis Res Ther       Date:  2017-04-11       Impact factor: 5.156

4.  Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid Arthritis.

Authors:  Leroy Shervington; Ashish Darekar; Murassa Shaikh; Roshini Mathews; Amal Shervington
Journal:  Biomark Insights       Date:  2018-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.